https://scholars.lib.ntu.edu.tw/handle/123456789/201384
標題: | A Novel Self-Expanding Nitinol Stent in Medically Refractory Intracranial Atherosclerotic Stenoses: The Wingspan Study | 作者: | Bose, A. Hartmann, M. Henkes, H. Liu, H. M. Teng, M. M.H. Szikora, I. Berlis, A. Reul, J. Yu, S. C.H. Forsting, M. Lui, M. Lim, W. Sit, S. P. 廖漢文 |
關鍵字: | atherosclerosis;medical therapy;nitinol stent;stenosis | 公開日期: | 2007 | 卷: | v.38 | 期: | n.5 | 起(迄)頁: | 1531-1537 | 來源出版物: | STROKE | 摘要: | Background and Purpose-: The purpose of this study was to assess the safety and performance of the Wingspan stent system and Gateway percutaneous transluminal angioplasty balloon catheter in the treatment of high-grade, intracranial atherosclerotic lesions in patients who had failed medical therapy. Methods-: In this prospective, multicenter, single -arm study, medically refractory patients with a modified Rankin score <=3 and recurrent symptoms attributable to angiographically demonstrated intracranial stenosis >=50% in a vessel 2.5 to 4.5 mm in diameter were enrolled. Intracranial lesions were predilated with an undersized Gateway balloon catheter to 80% of the native vessel diameter, followed by deployment of the self- expanding Wingspan stent to facilitate further remodeling of the atherosclerotic plaque and to maintain vessel patency. Neurologic examinations and angiograms were performed at 6 months after the procedure. Results-: Among the 45 patients enrolled, the degree of stenosis was reduced from a baseline of 74.9+/-9.8% to 31.9+/-13.6% after stenting and 28+/-23.2 % at the 6-month follow-up. The 30-day composite ipsilateral stroke/death rate was 4.5% (2/44); at the 6-month follow-up , the ipsilateral stroke/death rate was 7.0%, the rate for all strokes was 9 .7%, and all-cause mortality was 2.3%. Physician-reported follow-up in 43 patients (average of 13 months) conducted outside the study protocol (not adjudicated by the clinical event committee) reported 1 additional ipsilateral stroke. Conclusions-: In medically refractory patients with high-grade intracranial atherosclerotic stenoses, a new treatment paradigm involving predilation with an undersized Gateway percutaneous transluminal angioplasty balloon catheter and placement of a self- expanding Wingspan stent system appears to be safe, may facilitate remodeling, and may contribute to favorable angiographic outcomes.(C) 2007 American Heart Association, Inc. |
URI: | http://ntur.lib.ntu.edu.tw//handle/246246/87929 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。